Elutia to Participate in the Lake Street Capital Markets 10th Annual Big Ideas Growth Conference & the H.C. Wainwright 28th Annual Global Investment Conference
Elutia will meet investors and present on its drug-eluting biomatrix technology at two New York conferences in September 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Elutia (ELUT) will participate in two investor conferences in New York City in September 2026. Management will attend the Lake Street Capital Markets 10th Annual Big Ideas Growth Conference on September 10, 2026, for one-on-one investor meetings. The company will also present and hold one-on-one meetings at the H.C. Wainwright 28th Annual Global Investment Conference on September 15-16, 2026. A webcast of Elutia’s presentation on its drug-eluting biomatrix technology and its role in addressing post-surgical infections in plastic and reconstructive surgeries will be available on-demand following a live presentation beginning at 7:00 a.m. EDT on Friday, September 11, 2026.
Details
News Market Reaction – ELUT
On Sep 3, the first trading day after this news, ELUT closed 0.64% below the previous close.
Data tracked by StockTitan Argus for the Sep 3 session.
Key Figures
- Lake Street conference edition
- 10th annual
- Lake Street Capital Markets Big Ideas Growth Conference
- Lake Street meeting date
- September 10, 2026
- One-on-one investor meetings
- H.C. Wainwright conference edition
- 28th annual
- H.C. Wainwright Global Investment Conference
- H.C. Wainwright conference dates
- September 15-16, 2026
- Presentation and one-on-one investor meetings
- Presentation time
- 7:00am Eastern Daylight Time
- September 11, 2026 webcast
- Presentation date
- September 11, 2026
- H.C. Wainwright presentation
Historical Context
-
Completed sale added cash and focused resources on NXT-41x.
-
Funding, surgeon interest, regulatory timelines, and quarterly results were reported.
-
Avenue Capital provided financing, with an additional tranche tied to FDA clearance.
-
The company scheduled release of second-quarter financial results.
-
Elutia signed an agreement to sell SimpliDerm for up to $11 million.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
drug-eluting biomatrix technologies technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
GAITHERSBURG, Md., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) ("Elutia" or the "Company"), a pioneer in drug-eluting biomatrix technologies, today announced that Dr. Randy Mills, Chief Executive Officer, Matthew Ferguson, Chief Financial Officer, and Dr. Michelle Williams, Chief Scientific Officer, will participate in two upcoming investor conferences.
Lake Street Capital Markets 10th Annual Big Ideas Growth Conference
Elutia will host one-on-one meetings with investors at the Lake Street Capital Markets 10th Annual Big Ideas Growth Conference at the Metropolitan Club in New York City on September 10, 2026. To schedule a one-on-one meeting, institutional investors may contact their Lake Street representative.
H.C. Wainwright 28th Annual Global Investment Conference
Elutia will also present and host one-on-one meetings with investors at the H.C. Wainwright 28th Annual Global Investment Conference at the Lotte New York Palace Hotel in New York City on September 15-16, 2026.
During the presentation, management will discuss how Elutia is working to address post-surgical infection in plastic and reconstructive surgeries—one of the most significant challenges facing patients and surgeons—through its drug-eluting biomatrix technology designed to support safer, more reliable reconstructive outcomes.
The presentation will begin at 7:00am Eastern Daylight Time on Friday, September 11, 2026, and can be accessed on-demand here: Webcast. Elutia will also host one-on-one meetings with investors on September 15-16, 2026. To schedule a one-on-one meeting, visit H.C. Wainwright.
About Elutia
Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia's mission is humanizing medicine so patients can thrive without compromise. For more information, visit www.Elutia.com.
Investors:
Elutia Investor Relations
ir@elutia.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When will Elutia (ELUT) attend the Lake Street Capital Markets 10th Annual Big Ideas Growth Conference?
Elutia will participate in the Lake Street Capital Markets 10th Annual Big Ideas Growth Conference on September 10, 2026, at the Metropolitan Club in New York City, where the company will host one-on-one meetings with institutional investors.
How can investors schedule one-on-one meetings with Elutia (ELUT) at the Lake Street conference?
Institutional investors who wish to schedule one-on-one meetings with Elutia at the Lake Street Capital Markets 10th Annual Big Ideas Growth Conference may contact their Lake Street representative to arrange a meeting.
What are the dates and location of Elutia’s participation in the H.C. Wainwright 28th Annual Global Investment Conference?
Elutia will present and host one-on-one meetings at the H.C. Wainwright 28th Annual Global Investment Conference on September 15-16, 2026, at the Lotte New York Palace Hotel in New York City.
When is Elutia’s webcast presentation at the H.C. Wainwright Global Investment Conference and how can it be accessed?
Elutia’s presentation will begin at 7:00 a.m. Eastern Daylight Time on Friday, September 11, 2026, and can be accessed on-demand via a webcast link provided by the conference organizer.
How can investors arrange one-on-one meetings with Elutia (ELUT) at the H.C. Wainwright conference?
To schedule one-on-one meetings with Elutia during the H.C. Wainwright 28th Annual Global Investment Conference on September 15-16, 2026, investors are directed to visit H.C. Wainwright to arrange a meeting.
What topic will Elutia (ELUT) discuss during its H.C. Wainwright conference presentation?
Elutia’s management will discuss how the company is working to address post-surgical infection in plastic and reconstructive surgeries through its drug-eluting biomatrix technology, which is designed to support safer, more reliable reconstructive outcomes.